In ever-changing field environments, conditions can shift rapidly, eroding the best-laid plans with little time to react. Throughout my years working in clinical trials, I've found that this type of ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

China’s first attempt to land an orbital-class rocket may have ended in a fiery crash, but the company responsible for the mission had a lot to celebrate with the first flight of its new ...

This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Nov. 18 (UPI) --Google announced Tuesday it was rolling out the latest iteration of its Gemini AI model as the search engine giant tries to keep up with competitor OpenAI. Sundar Pichai, CEO of Google ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Brendan Fraser and Rachel Weisz are reuniting for another “Mummy” adventure. Filmmakers Matt Bettinelli-Olpin and Tyler Gillett, who call themselves Radio Silence, are set to direct the fourth ...

Recursion Pharmaceuticals merged with Exscientia, another AI-driven drug discovery company, positioning itself as a potential biotech innovator The company has partnerships with major pharmaceutical ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...